Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitefrazierhealthcare...
Phone206.621.7200
Employees
Founded1991

Funds

Total$977M
Frazier Healthcare VII LP, 10/2013 $377M
Frazier Healthcare VI, 11/2007 $600M

Offices

Seattle OFFICE
601 Union, Two Union Square, Suite 3200
Seattle, WA, 98101
USA
Menlo Park office
70 Willow Rd, Suite 200
Menlo Park, CA, 94025
USA

People

General Partner
General Partner
General Partner
General Partner
General Partner
Partner
COO & General Partner
Operating Partner
Show All People

Tags

Frazier Healthcare Ventures

Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and growth equity capital to emerging biopharma, medical device and healthcare service companies. With over $1.8 billion under management, Frazier Healthcare has invested in over 100 companies across the entire developmental spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare Ventures has established itself among entrepreneurs and seasoned executives as the preferred partner to grow successful healthcare companies.

Recent Milestones

Investments

Company Date Round Size Participants
PowerVision 1/2014Series D$20M6
PreCision Dermatology 9/2013Debt$67M7
Alcresta 7/2013Series B$10M3
Achaogen 3/2013Private Equity$18.9M7
Glaukos 2/2013Series F$30M7
Atterocor 8/2012Series A$16M3
Alcresta 4/2012Series A$10M3
Kalidex Pharmaceuticals 1/2012Venture Round$6.5M6
Moximed 1/2012Private Equity$1.77M4
Allena Pharmaceuticals 11/2011Series A$15M3
Rempex Pharmaceuticals 11/2011Series B$67.5M5
PowerVision 7/2011Series C$24M5
Chimerix 2/2011Series F$45M8
Tobira Therapeutics 9/2010Series B$31M5
Nuon Therapeutics 8/2010Venture Round$10M3
BARRX Medical 7/2010Series D$15M6
Calistoga Pharmaceuticals 6/2010Series C$40M6
Incline Therapeutics 6/2010Series A$43M6
Zeltiq Aesthetics 6/2010Series D$25M4
Achaogen 4/2010Series C$56M7
Nuon Therapeutics 3/2010Venture Round$6.05M3
VentiRx Pharmaceuticals 1/2010Series A$51.6M4
Calibra Medical 11/2009Venture Round$1.4M5
Calypso Medical 11/2009Series E$50M4
Barosense 8/2009Series D$27M8
Clovis Oncology 5/2009Private Equity$145M7
Calistoga Pharmaceuticals 5/2009Series B$30M4
Stemgent 3/2009Series B$14M2
Primaeva Medical 2/2009Series C$6M3
Intradigm Corporation 1/2009Series B$21.4M8
Alnara Pharmaceuticals 10/2008Series A$20M3
Glaukos 8/2008Series D$35M7
PatientKeeper 8/2008Venture Round$7.5M3
EBR Systems 6/2008Series C$35M5
Nuon Therapeutics 4/2008Series B$27M2
Stromedix 4/2008Series B$25M5
Zonare Medical Systems 2/2008Venture Round$30M8
PowerVision 12/2007Series B$20M3
AnaptysBio 11/2007Series B$33M6
Zeltiq Aesthetics 10/2007Series B$20.3M2
FlowCardia 8/2007Series C$30M9
Marcadia Biotech 5/2007Series A$15M3
Stromedix 3/2007Series A$1M2
Calistoga Pharmaceuticals 3/2007Series A$21M4
Chimerix 2/2007Series D$23.1M4
Primaeva Medical 12/2006Series B$7M2
Intradigm Corporation 11/2006Series A$16M5
PatientKeeper 6/2006Venture Round$8M7
Juniper Medical 3/2006Series A$7.5M2
Primaeva Medical 2006Series A$1.25M2
Barosense 2006Venture Round$6.2M2
EBR Systems 10/2005Venture Round$21M4
Glaukos 9/2002Series A$10M3

Videos

Sources

  1. Frazier Healthcare Closes Seventh Fund at $377M (finsmes.com) [edit]
  2. Life science fund Frazier Healthcare VI closes on $600m (altassets.net) [edit]
  3. PowerVision Raises $20M in Series D Funding (finsmes.com) [edit]
  4. Skincare company PreCision Dermatology receives $67 mln from Golub Capital (pehub.com) [edit]
  5. Alcresta Raises $10M in Series B Financing (finsmes.com) [edit]
  6. VC Funding - Q2 2013 [edit]
  7. Glaukos Spots $30M for Eyeball Stent, Doesn't Blink in Ivantis Rivalry (pevc.dowjones.com) [edit]
  8. Atterocor Raises $16M in Series A Funding (finsmes.com) [edit]
  9. Alcresta Raises $10M in Series A Financing (finsmes.com) [edit]
  10. VC Funding: Q1 2012 [edit]
  11. VC Funding: Q1 2012 [edit]
  12. Allena Pharmaceuticals Raises $15M in Series A Venture Capital Financing (finsmes.com) [edit]
  13. Rempex Announces Series B Financing of up to $67.5 Million (rempexpharma.com) [edit]
  14. PowerVision Closes $24M Series C Financing (finsmes.com) [edit]
  15. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 (chimerix-inc.com) [edit]
  16. Tobira Therapeutics Inc. Raises $31 Million in Series B Financing (tobiratherapeutics.com) [edit]
  17. Nuon Therapeutics raises $10M in new funding (bizjournals.com) [edit]
  18. BÂRRX Medical, Inc. Completes $15 Million Growth Financing (barrx.com) [edit]
  19. Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com) [edit]
  20. Incline Therapeutics, Inc.: Series A $43M (onbiovc.com) [edit]
  21. AltAssets (altassets.com) [edit]
  22. Achaogen Completes $56 Million Series C Financing (pr-inside.com) [edit]
  23. Nuon captures $6.05M to develop treatments for autoimmune disease (venturebeat.com) [edit]
  24. VentiRx Pharma Extends Series A To $51.6M (fis.dowjones.com) [edit]
  25. Calibra takes $1.4M to for insulin delivery devices (venturebeat.com) [edit]
  26. Calypso Medical Technologies, Inc.: Series E $50M (onbiovc.com) [edit]
  27. Barosense bags $27M for obesity treatment (venturebeat.com) [edit]
  28. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
  29. Capital Report Index [edit]
  30. Stemgent Nails Down $14M to Make Supplies, Tools for Stem Cell Researchers (xconomy.com) [edit]
  31. Primaeva Medical raises $6M for aging skin (venturebeat.com) [edit]
  32. Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive (fiercebiotech.com) [edit]
  33. Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round (xconomy.com) [edit]
  34. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  35. Equity Help Desk (equityhelpdesk.com) [edit]
  36. Capital Funding Report [edit]
  37. Nuon Therapeutics, Inc. Completes $27 Million Series B Financing (nuontherapeutics.com) [edit]
  38. Capital Funding Report [edit]
  39. Compact-ultrasound maker Zonare Medical raises $30M (venturebeat.com) [edit]
  40. VentureBeat (venturebeat.com) [edit]
  41. AnaptysBio raises over $33 million in Series B financing (anaptysbio.com) [edit]
  42. Zeltiq raises $20.3M for fat reduction (venturebeat.com) [edit]
  43. FlowCardia, Inc. Raises $30 Million In Series C Financing (flowcardia.com) [edit]
  44. MARCADIA BIOTECH COMPLETES $15 MILLION SERIES A FINANCING (marcadiabiotech.com) [edit]
  45. EDGAR [edit]
  46. Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing (calistogapharma.com) [edit]
  47. Chimerix Raises $23.1 Million to Advance Antiviral Drug Pipeline (prnewswire.com) [edit]
  48. EDGAR [edit]
  49. INTRADIGM ANNOUNCES SIGNIFICANT ENHANCEMENTS OF THE COMPANY CAPABILITIES, A NEW SERIES A FINANCING AND IMPORTANT ADDITION TO SENIOR MANAGEMENT TEAM (intradigm.com) [edit]
  50. PatientKeeper Closes $8 Million Financing to Support Continued Rapid Growth (patientkeeper.com) [edit]
  51. EDGAR [edit]
  52. EDGAR [edit]
  53. iNovia Source [edit]
  54. EDGAR [edit]
  55. Glaukos Receives Series A Investment From Domain Associates, LLC, Versant Ventures, And Frazier Healthcare Ventures (privco.com) [edit]
Edit This Page
Last Edited 3/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy